Enzymatic function of nitric oxide synthases

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 521-531

  Andrew, Penelope J ^a   Mayer, Bernd ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Endothelial factors; Endothelial function; Free radicals; Nitric oxide; Vasoconstriction dilation

Indexed keywords

ANION; ARGININE; CALCIUM ION; CALMODULIN; CITRULLINE; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; FREE RADICAL; HEME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; OXYGENASE; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; TETRAHYDROBIOPTERIN;

BIOSYNTHESIS; CATALYSIS; CRYSTAL STRUCTURE; DIMERIZATION; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTION ANALYSIS; REVIEW; STRUCTURE ANALYSIS; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ANTIOXIDANTS; ARGININE; BIOPTERIN; CALCIUM; CALMODULIN; DIMERIZATION; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HEME; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III;

EID: 0033567065     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00115-7     Document Type: Review

References (135)

1. Palmer R.M.J., Ferige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
2. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA. 88:1991;4651-4655.
3. Radomski M.W., Palmer R.M.J., Moncada S. Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. Trends Pharmacol Sci. 12:1991;87-88.
4. Scott-Burden T., Vanhoutte P.M. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation. 87:(Suppl V):1993;V51-V55.
5. Mayer B., Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci. 22:1997;477-481.
6. Hemmens B., Mayer B. Enzymology of nitric oxide synthases. Titheradge M. Methods in molecular biology. Nitric oxide protocols. 1st ed :1998;1-32 Humana Press, Totowa, NJ.
7. Stuehr D.J. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol. 37:1997;339-359.
8. Ayajiki K., Kindermann M., Hecker M., Fleming I., Busse R. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res. 78:1996;750-758.
9. Griffith O.W., Stuehr D.J. Nitric oxide synthases: Properties and catalytic mechanism. Annu Rev Physiol. 57:1995;707-736.
10. Korth H.-G., Sustmann R., Thater C., Butler A.R., Ingold K.U. On the mechanism of the nitric oxide synthase-catalyzed conversion of Nω-hydroxy-L-arginine to citrulline and nitric oxide. J Biol Chem. 269:1994;17776-17779.
11. Marletta M.A. Nitric oxide synthase structure and mechanism. J Biol Chem. 268:1993;12231-12234.
12. Abu-Soud H.M., Presta A., Mayer B., Stuehr D.J. Analysis of neuronal NO synthase under single-turnover conditions: conversion of Nω-hydroxyarginine to nitric oxide and citrulline. Biochemistry. 36:1997;10811-10816.
13. Mayer B., John M., Heinzel B., et al. Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett. 288:1991;187-191.
14. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 281:1992;627-630.
15. Huk I., Nanobashvili J., Neumayer C., et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation. 96:1997;667-675.
16. Stuehr D.J., Kwon N.S., Nathan C.F., et al. Nω-Hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-Arginine. J Biol Chem. 266:1991;6259-6263.
17. Ghosh D.K., Stuehr D.J. Macrophage NO synthase: Characterization of isolated oxygenase and reductase domains reveals a head-to-head subunit interaction. Biochemistry. 34:1995;801-807.
18. G-hydroxy-L-arginine as an intermediate. J Biol Chem. 268:1993;14781-14787.
19. Abu-Soud H.M., Yoho L.L., Stuehr D.J. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism: Activation of intra- and interdomain electron transfer. J Biol Chem. 269:1994;32047-32050.
20. Bredt D.S., Hwang P.M., Glatt C.E., et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P450 reductase. Nature. 351:1991;714-718.
21. Xie Q., Cho H., Kashiwabara Y., et al. Carboxyl terminus of inducible nitric oxide synthase: Contribution to NADPH binding and enzymatic activity. J Biol Chem. 269:1994;28500-28505.
22. Zhang J.L., Patel J.M., Li Y.D., Block E.R. Reductase domain cysteines 1048 and 1114 are critical for catalytic activity of human endothelial cell nitric oxide synthase as probed by site-directed mutagenesis. Biochem Biophys Res Commun. 226:1996;293-300.
23. Chen P.-F., Tsai A.-L., Wu K.K. Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Commun. 215:1995;1119-1129.
24. Cho H.J., Martin E., Xie Q.W., Sassa S., Nathan C. Inducible nitric oxide synthase: Identification of amino acid residues essential for dimerization and binding of tetrahydrobiopterin. Proc Natl Acad Sci USA. 92:1995;11514-11518.
25. Nishimura J., Martasek P., McMillan K., et al. Modular structure of neuronal nitric oxide synthase: Localization of the arginine binding site and modulation by pterin. Biochem Biophys Res Commun. 210:1995;288-294.
26. Gachhui R., Ghosh D.K., Wu C., et al. Mutagenesis of acidic residues in the oxygenase domain of inducible nitric-oxide synthase identifies a glutamate involved in arginine binding. Biochemistry. 36:1997;5097-5103.
27. Chen P.-F., Tsai A.L., Berka V., Wu K.K. Mutation of Glu-361 in human endothelial nitric-oxide synthase selectively abolishes L-arginine binding without perturbing the behavior of heme and other redox centers. J Biol Chem. 272:1997;6114-6118.
28. Siddhanta U., Presta A., Fan B., et al. Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups located on adjacent subunits in the dimer. J Biol Chem. 273:1998;18950-18958.
29. Crane B.R., Arvai A.S., Ghosh D.K., et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science. 279:1998;2121-2126.
30. Raman C.S., Li H., Martásek P., et al. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell. 95:1998;939-950.
31. Klatt P., Pfeiffer S., List B.M., et al. Characterisation of heme-deficient neuronal nitric oxide synthase reveals a role for heme in subunit dimerisation and binding of the amino acid substrate and tetrahydrobiopterin. J Biol Chem. 271:1996;7336-7342.
32. Baek K.J., Thiel B.A., Lucas S., Stuehr D.J. Macrophage nitric oxide synthase subunits: Purification, characterisation, and role of prosthetic groups and substrate in regulating their association into a dimeric enzyme. J Biol Chem. 268:1993;21120-21129.
33. List B.M., Klösch B., Völker C., et al. Characterization of bovine endothelial nitric oxide synthase as a homodimer with down-regulated uncoupled NADPH oxidase activity: tetrahydrobiopterin binding kinetics and role of haem in dimerization. Biochem J. 323:1997;159-165.
34. Chen P., Tsai A., Wu K.K. Cysteine 184 of endothelial nitric oxide synthase is involved in heme coordination and catalytic activity. J Biol Chem. 269:1994;25062-25066.
35. Xie Q.-W., Leung M., Fuortes M., Sassa S., Nathan C. Complementation analysis of mutants of nitric oxide synthase reveals that the active site requires two hemes. Proc Natl Acad Sci USA. 93:1996;4891-4896.
36. Richards M.K., Marletta M.A. Characterization of neuronal nitric oxide synthase and a C415H mutant, purified from a baculovirus overexpression system. Biochemistry. 33:1994;14723-14732.
37. Hemmens B., Gorren A.C.F., Schmidt K., Werner E.R., Mayer B. Haem insertion, dimerization and reactivation of haem-free rat neuronal nitric oxide synthase. Biochem J. 332:1998;337-342.
38. Brunner K., Tortschanoff A., Hemmens B., et al. Sensitivity of flavin fluorescence dynamics in neuronal nitric oxide synthase to cofactor-induced conformational changes and dimerization. Biochemistry. 37:1998;17545-17553.
39. Pufahl R.A., Marletta M.A. Oxidation of N-hydroxy-L-Arg by nitric oxide synthase: Evidence for involvement of heme in catalysis. Biochem Biophys Res Commun. 193:1993;963-970.
40. Presta A., Liu J., Sessa W.C., Stuehr D.J. Substrate binding and calmodulin binding to endothelial nitric oxide synthase co-regulate its enzymatic activity. Nitric Oxide. 1:1997;74-87.
41. Abu-Soud H.M., Feldman P.L., Clark P., Stuehr D.J. Electron transfer in the nitric-oxide synthases. Characterization of L-arginine analogs that block heme iron reduction. J Biol Chem. 269:1994;32318-32326.
42. Salerno J.C., McMillan K., Masters B.S. Binding of intermediate, product, and substrate analogs to neuronal nitric oxide synthase: ferriheme is sensitive to ligand-specific effects in the L-arginine binding site. Biochemistry. 35:1996;11839-11845.
43. McMillan K., Masters B.S.S. Optical difference spectrophotometry as a probe of rat brain nitric oxide synthase heme-substrate interaction. Biochemistry. 32:1993;9875-9880.
44. Sennequier N., Stuehr D.J. Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase. Biochemistry. 35:1996;5883-5892.
45. Rodríguez-Crespo I., Gerber N.C., OrtizdeMontellano P.R. Endothelial nitric-oxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. J Biol Chem. 271:1996;11462-11467.
46. Salerno J.C., Martasek P., Roman L.J., Masters B.S. Electron paramagnetic resonance spectroscopy of the heme domain of inducible nitric oxide synthase: binding of ligands at the arginine site induces changes in the heme ligation geometry. Biochemistry. 35:1996;7626-7630.
47. Gorren A.C.F., List B.M., Schrammel A., et al. Tetrahydrobiopterin-free neuronal nitric oxide synthase: Evidence for two identical highly anticooperative pteridine binding sites. Biochemistry. 35:1996;16735-16745.
48. Venema R.C., Ju H., Zou R., Ryan J.W., Venema V.J. Subunit interactions of endothelial nitric-oxide synthase: Comparisons to the neuronal and inducible nitric-oxide synthase isoforms. J Biol Chem. 272:1997;1276-1282.
49. Wu C., Zhang J., Abu-Soud H., Ghosh D.K., Stuehr D.J. High-level expression of mouse inducible nitric oxide synthase in Escherichia coli requires coexpression with calmodulin. Biochem Biophys Res Commun. 222:1996;439-444.
50. Klatt P., Schmidt K., Lehner D., et al. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer. EMBO J. 14:1995;3687-3695.
51. Mayer B., Wu C., Gorren A.C.F., et al. Tetrahydrobiopterin binding to macrophage inducible nitric oxide synthase: heme spin shift and dimer stabilization by the potent pterin antagonist 4-amino-tetrahydrobiopterin. Biochemistry. 36:1997;15091-15095.
52. Ghosh D.K., Wu C., Pitters E., et al. Characterization of the inducible nitric oxide synthase oxygenase domain identifies a 49 amino acid segment required for subunit dimerization and tetrahydrobiopterin interaction. Biochemistry. 36:1997;10609-10619.
53. Werner E.R., Pitters E., Schmidt K., Wachter H., et al. Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase. Biochem J. 320:1996;193-196.
54. Pfeiffer S., Gorren A.C.F., Pitters E., et al. Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-aminotetrahydrobiopterin. Biochem J. 328:1997;349-352.
55. Mayer B., Werner E.R. In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn-Schmiedeberg's Arch Pharmacol. 351:1995;453-463.
56. Giovanelli J., Campos K.L., Kaufman S. Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine. Proc Natl Acad Sci USA. 88:1991;7091-7095.
57. Kaufman S. Tyrosine hydroxylase. Adv Enzymol Relat Areas Mol Biol. 70:1995;103-220.
58. Presta A., Siddhanta U., Wu C., et al. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase. Biochemistry. 37:1998;298-310.
59. Abu-Soud H.M., Gachhui R., Raushel F.M., Stuehr D.J. The ferrous-dioxy complex of neuronal nitric oxide synthase: Divergent effects of L-arginine and tetrahydrobiopterin on its stability. J Biol Chem. 272:1997;17349-17353.
60. Venema R.C., Sayegh H.S., Kent J.D., Harrison D.G. Identification, characterisation, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J Biol Chem. 271:1996;6435-6440.
61. Salerno J.C., Harris D.E., Irizarry K., et al. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem. 272:1997;29769-29777.
62. Venema R.C., Sayegh H.S., Arnal J.-F., Harrison D.G. Role of the enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase. J Biol Chem. 270:1995;14705-14711.
63. Abu-Soud H.M., Stuehr D.J. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci USA. 90:1993;10769-10772.
64. Gorren A.C.F., Schrammel A., Schmidt K., Mayer B. Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization. Biochemistry. 36:1997;4360-4366.
65. Abe J., Berk B.C. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med. 8:1998;59-64.
66. Laursen J.B., Rajagopalan S., Galis Z., et al. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 95:1997;588-593.
67. Mügge A., Elwell J.H., Peterson T.E., et al. Chronic treatment with polyethylene glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 69:1991;1293-1300.
68. White C.R., Brock T.A., Chang L.-Y., et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 91:1994;1044-1048.
69. Presta A., Weber-Main A.M., Stankovich M.T., Stuehr D.J. Comparative effects of substrates and pterin cofactor on the heme midpoint potential in inducible and neuronal nitric oxide synthases. J Am Chem Soc. 120:1998;9460-9465.
70. Gonzalez-Zulueta M., Ensz L.M., Mukhina G., et al. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J Neurosci. 18:1998;2040-2055.
71. Albina J.E., Mills C.D., Henry W.L. Jr., Caldwell M.D. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J Immunol. 144:1990;3877-3880.
72. Xia Y., Roman L.J., Masters B.S., Zweier J.L. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem. 273:1998;22635-22639.
73. Cosentino F., Patton S., d́Uscio L.V., et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest. 101:1998;1530-1537.
74. Pritchard K.A., Groszek L., Smalley D.M., et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res. 77:1995;510-518.
75. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem. 273:1998;25804-25808.
76. Vásquez-Vivar J., Kalyanaraman B., Martásek P., et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA. 95:1998;9220-9225.
77. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 40:1996;C1424-C1437.
78. Mayer B., Pfeiffer S., Schrammel A., et al. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J Biol Chem. 273:1998;3264-3270.
79. Griscavage J.M., Fukoto J.M., Komori Y., Ignarro L.J. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. J Biol Chem. 269:1994;21644-21649.
80. Abu-Soud H.M., Wang J., Rousseau D.L., et al. Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biol Chem. 270:1995;22997-23006.
81. Mayer B., Klatt P., Werner E.R., Schmidt K. Kinetics and mechanism of tetrahydrobiopterin-induced oxidation of nitric oxide. J Biol Chem. 270:1995;655-659.
82. Myers P.R., Minor R.L. Jr., Guerra R. Jr., Bates J.N., Harrison D.G. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 345:1990;161-163.
83. Davidson C.A., Kaminski P.M., Wu M., Wolin M.S. Nitrogen dioxide causes pulmonary arterial relaxation via thiol nitrosation and nitric oxide formation. Am J Physiol. 270:1996;H1038-H1043.
84. Beckman J.S., Ye Y.Z., Anderson P., et al. Extensive nitration of protein tyrosines observed in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler. 375:1994;81-88.
85. Pfeiffer S., Mayer B. Lack of tyrosine nitration by peroxynitrite generated at physiological pH. J Biol Chem. 273:1998;27280-27285.
86. Eiserich J.P., Hristova M., Cross C.E., et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 391:1998;393-397.
87. Vanhoutte P.M. Endothelial dysfunction and atherosclerosis. Eur Heart J. 18:(Suppl E):1997;E19-E29.
88. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 100:1997;2153-2157.
89. Balligand J.-L., Kelly R.A., Marsden P.A., Smith T.W., Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA. 90:1993;347-351.
90. Schulz R., Smith J.A., Lewis M.J., Moncada S. Nitric oxide synthesis in cultured endocardial cells of the pig. Br J Pharmacol. 104:1991;21-24.
91. Liao J.K., Zulueta J.J., Yu F.-S., et al. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest. 96:1995;2661-2666.
92. Goetz R.M., Morano I., Calovini T., Studer R., Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun. 205:1994;905-910.
93. Sessa W.C., Pritchard K., Seyedi N., Wang J., Hintze T.H. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res. 74:1994;349-353.
94. Rees D.D., Palmer R.M., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
95. Boulanger C.M., Vanhoutte P.M. G proteins and endothelium-dependent relaxations. J Vasc Res. 34:1997;175-185.
96. Nishida K., Harrison D.G., Navas J.P., et al. Molecular cloning and characterisation of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 90:1992;2092-2096.
97. Awolesi M.A., Sessa W.C., Sumpio B.E. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest. 96:1995;1449-1454.
98. Ohno M., Gibbons G.H., Dzau V.J., Cooke J.P. Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling. Circulation. 88:1993;193-197.
99. Shaul P.W., Smart E.J., Robinson L.J., et al. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 271:1996;6518-6522.
100. García-Cardeña G., Martásek P., Masters B.S.S., et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin: Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem. 272:1997;25437-25440.
101. Ghosh S., Gachhui R., Crooks C., Wu C., Lisanti M., Stuehr D.J. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J Biol Chem. 273:1998;22267-22271.
102. Ju H., Venema V.J., Marrero M.B., Venema R.C. Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. J Biol Chem. 273:1998;24025-24029.
103. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 272:1997;6525-6533.
104. Robinson L.J., Busconi L., Michel T. Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem. 270:1995;995-998.
105. Feron O., Michel J.B., Sase K., Michel T. Dynamic regulation of endothelial nitric oxide synthase: Complementary roles of dual acylation and caveolin interactions. Biochemistry. 37:1998;193-200.
106. Ignarro L.J., Bush P.A., Buga G.M., et al. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun. 170:1990;843-850.
107. Rand M.J., Li C.G. Nitric oxide as a neurotransmitter in peripheral nerves: Nature of transmitter and mechanism of transmission. Annu Rev Physiol. 57:1995;659-682.
108. Kennedy M.B. Origin of PDZ (DHR, GLGF) domains. Trends Biochem Sci. 20:1995;350.
109. Brenman J.E., Chao D.S., Xia H.H., Aldape K., Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 82:1995;743-752.
110. Brenman J.E., Chao D.S., Gee S.H., et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha 1-syntrophin mediated by PDZ domains. Cell. 84:1996;757-767.
111. Stricker N.L., Christopherson K.S., Yi B.A., et al. PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences. Nat Biotechnol. 15:1997;336-342.
112. Venema V.J., Ju H., Zou R., Venema R.C. Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem. 272:1997;28187-28190.
113. Huang Z.H., Huang P.L., Panahian N., et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
114. MacMicking J.D., Nathan C., Hom G., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
115. Gross S.S., Jaffe E.A., Levi R., Kilbourn R.G. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent, and inhibited by arginine analogues. Biochem Biophys Res Commun. 178:1991;823-829.
116. Balligand J.-L., Ungureanu-Longrois D., Simmons W.W., et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem. 269:1994;27580-27588.
117. Geller D.A., Lowenstein C.J., Shapiro R.A., et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA. 90:1993;3491-3495.
118. Buttery L.D.K., Springall D.R., Chester A.H., et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 75:1996;77-85.
119. Kessler P., Bauersachs J., Busse R., Schini-Kerth V.B. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler Thromb Vasc Biol. 17:1997;1746-1755.
120. Shears L.L. II, Kawaharada N., Tzeng E., et al. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest. 100:1997;2035-2042.
121. Wheeler M.A., Smith S.D., García-Cardeña G., Nathan C.F., Weiss R.M., Sessa W.C. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest. 99:1997;110-116.
122. Vodovotz Y., Russell D., Xie Q.-W., Bogdan C., Nathan C. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J Immunol. 154:1995;2914-2925.
123. Schmidt H.H.H.W., Warner T.D., Nakane M., Förstermann U., Murad F. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol. 41:1992;615-624.
124. Vidal F., Colomé C., Martínez-González J., Badimon L. Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells. Eur J Biochem. 252:1998;378-384.
125. Bogle R.G., Baydoun A.R., Pearson J.D., Moncada S., Mann G.E. L. L-Arginine transport is increased in macrophages generating nitric oxide. Biochem J. 284:1992;15-18.
126. Nüssler A.K., Billiar T.R., Liu Z.-Z., Morris S.M. Jr. Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line: implications for regulation of nitric oxide production. J Biol Chem. 269:1994;1257-1261.
127. Corraliza I.M., Soler G., Eichmann K., Modolell M. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun. 206:1995;667-673.
128. Werner E.R., Werner-Felmayer G., Mayer B. Tetrahydrobiopterin, cytokines and nitric oxide. Proc Soc Exp Biol Med. 219:1998;171-182.
129. Hecker M., Sessa W.C., Harris H.J., Anggard E.E., Vane J.R. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured human endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci USA. 87:1990;8612-8616.
130. Arnal J.F., Münzel T., Venema R.C., et al. Interactions between L-arginine and L-glutamine change endothelial NO production: An effect independent of NO synthase substrate availability. J Clin Invest. 95:1995;2565-2572.
131. Pollock J.S., Förstermann U., Mitchell J.A., et al. Purification and characterisation of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA. 88:1991;10480-10484.
132. Theilmeier G., Chan J.R., Zalpour C., et al. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine. Arterioscler Thromb Vasc Biol. 17:1997;3557-3564.
133. Bode-Boger S.M., Boger R.H., Kienke S., Junker W., Frohlich J.C. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun. 219:1996;598-603.
134. Giugliano D., Marfella R., Verrazzo G., et al. The vascular effects of L-arginine in humans. The role of endogenous insulin. J Clin Invest. 99:1997;433-438.
135. MacAllister R.J., Calver A.L., Collier J., et al. Vascular and hormonal responses to arginine: provision of substrate for nitric oxide or non-specific effect? Clin Sci Colch. 89:1995;183-190.